GUEST OVERVIEW: Steve Kirsch is a Silicon Valley entrepreneur and philanthropist who founded the COVID-19 Early Treatment Fund (CETF) at the beginning of the pandemic. Steve and CETF funded the research that showed promising results of fluvoxamine as an early treatment of COVID-19. The study was also featured on 60 Minutes. Recently Steve founded the Vaccine Safety Research Foundation, where he is working with over 20 scientists, doctors, and statisticians researching the safety of the COVID-19 vaccines.
To leave or reply to comments, please download free Podbean or
To leave or reply to comments, please download free Podbean App.